These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 11427987)
21. Developments in the systemic therapy of pancreatic cancer. el-Rayes BF; Shields AF; Vaitkevicius V; Philip PA Cancer Invest; 2003; 21(1):73-86. PubMed ID: 12643012 [TBL] [Abstract][Full Text] [Related]
22. Gemcitabine resistance in pancreatic ductal adenocarcinoma. Binenbaum Y; Na'ara S; Gil Z Drug Resist Updat; 2015 Nov; 23():55-68. PubMed ID: 26690340 [TBL] [Abstract][Full Text] [Related]
23. Systemic therapy for advanced pancreatic cancer. El-Rayes BF; Philip PA Expert Rev Anticancer Ther; 2002 Aug; 2(4):426-36. PubMed ID: 12647986 [TBL] [Abstract][Full Text] [Related]
25. [Molecular-based treatment concepts in advanced pancreatic cancer]. Boeck S; Moosmann N; Stemmler HJ; Heinemann V Dtsch Med Wochenschr; 2007 Apr; 132(15):818-22. PubMed ID: 17427093 [No Abstract] [Full Text] [Related]
26. What's new in pancreatic cancer treatment pipeline? Von Hoff DD Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):315-26. PubMed ID: 16549330 [TBL] [Abstract][Full Text] [Related]
27. Present and future treatment of pancreatic cancer. Heinemann V Semin Oncol; 2002 Jun; 29(3 Suppl 9):23-31. PubMed ID: 12094335 [TBL] [Abstract][Full Text] [Related]
28. Biological approaches to therapy of pancreatic cancer. Wong HH; Lemoine NR Pancreatology; 2008; 8(4-5):431-61. PubMed ID: 18724071 [TBL] [Abstract][Full Text] [Related]
29. [Gene therapy of pancreatic cancer with microencapsulated CYP2B1-expressing cells]. Löhr M; Faulmann G; Hummel F; Singer MV Onkologie; 2001 Sep; 24 Suppl 5():60-4. PubMed ID: 11600815 [No Abstract] [Full Text] [Related]
31. [Second line chemotherapy for pancreatic cancer]. Park JY Korean J Gastroenterol; 2011 Apr; 57(4):207-12. PubMed ID: 21519173 [TBL] [Abstract][Full Text] [Related]
32. [The update on pancreatic cancer chemotherapy]. Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647 [TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer: what the oncologist can offer for palliation. Moore MJ Can J Gastroenterol; 2002 Feb; 16(2):121-4. PubMed ID: 11875597 [TBL] [Abstract][Full Text] [Related]
34. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Makrilia N; Syrigos KN; Saif MW JOP; 2011 Jul; 12(4):351-4. PubMed ID: 21737894 [TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Garrido-Laguna I; Hidalgo M Nat Rev Clin Oncol; 2015 Jun; 12(6):319-34. PubMed ID: 25824606 [TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy. Amedei A; Niccolai E; Prisco D Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives. Hosseini M; Hassanian SM; Mohammadzadeh E; ShahidSales S; Maftouh M; Fayazbakhsh H; Khazaei M; Avan A J Cell Biochem; 2017 Jul; 118(7):1634-1638. PubMed ID: 28106283 [TBL] [Abstract][Full Text] [Related]
39. Advanced pancreatic cancer: is there a role for combination therapy? Kulke MH Expert Rev Anticancer Ther; 2003 Oct; 3(5):729-39. PubMed ID: 14599095 [TBL] [Abstract][Full Text] [Related]
40. Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. Gounaris I; Zaki K; Corrie P JOP; 2010 Mar; 11(2):113-23. PubMed ID: 20208317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]